Illumina (ILMN) Sinks as Roche Deal Put on Ice

January 7, 2013 7:12 AM EST Send to a Friend
Illumina, Inc. (NASDAQ: ILMN) is under pressure early after Roche CEO Franz Humer said a deal is now "off the table" because the company is demanding too much.

Illumina reportedly asked Roche for $75/share and previously asked for $68/share.

This morning, Illumina announced the acquisition of Varinta Health for $450 million.

Shares of Illumina last traded at $48.48, down 11.5 percent.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Rumors, Trader Talk

Add Your Comment